Neurology Minute

American Academy of Neurology
undefined
Mar 17, 2025 • 2min

Neurology on the Hill 2025 - Part 1

In the first installment of this three-part series, Dr. Jason Crowell discusses the impact cuts to the Medicare Fee Scheduler has on patient care and the field of neurology. Show reference: https://www.aan.com/advocacy/
undefined
Mar 14, 2025 • 3min

Frontotemporal Dementia Differential Diagnosis in Clinical Practice

Dr. Trey Bateman and Dr. Amy Brodtmann discuss referrals for frontal network impairment and FTD, highlighting the most helpful information for reaching a final diagnosis after evaluation. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200360
undefined
Mar 13, 2025 • 2min

The Best of Headache Medicine from 2024: A Year in Review

Dr. Tesha Monteith and Dr. Patricia Pozo-Rosich discuss the latest advancements in headache medicine, focusing on key research findings from 2024.
undefined
Mar 13, 2025 • 2min

The Best of Headache Medicine from 2024: A Year in Review

Dr. Tesha Monteith and Dr. Patricia Pozo-Rosich discuss the latest advancements in headache medicine, focusing on key research findings from 2024.
undefined
Mar 12, 2025 • 1min

Sleep and Brain Health

Dr. Alberto Ramos discusses the importance of sleep for brain health.
undefined
Mar 11, 2025 • 2min

Sleep Apnea and Stroke Risk

Dr. Alberto Ramos discusses how managing risk factors for sleep apnea can significantly reduce systemic vascular risks and preserve neurologic function.
undefined
Mar 10, 2025 • 2min

Association of Migraine Treatments with Reduced Ischemic Stroke Risk

A fascinating look into how migraine treatments can influence ischemic stroke risk. The discussion highlights a significant study indicating that female patients using propranolol saw reduced stroke rates. It emphasizes the need for more research in this promising area, showcasing the intersection of neurology and headache management.
undefined
Mar 7, 2025 • 3min

Investigating Whether Dissemination in Time Is Essential to Diagnose Relapsing MS

Dr. Alison Christy and Dr. Wallace J. Brownlee discuss whether dissemination in time is necessary to make a diagnosis of MS in patients who fulfill a high number of dissemination in space criteria. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000210274
undefined
Mar 6, 2025 • 3min

Overview from the 2025 International Stroke Conference - Part 2

In part two of this two-part series, Dr. Andy Southerland and Dr. Seemant Chaturvedi discuss the PRESTIAGE-AF trial. Show references: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00333-2/fulltext
undefined
Mar 5, 2025 • 3min

Overview from the 2025 International Stroke Conference - Part 1

In part one of this two-part series, Dr. Andy Southerland and Dr. Seemant Chaturvedi discuss two trials that were looking at the use of endovascular therapy for medium vessel occlusion. Show references: https://www.nejm.org/doi/full/10.1056/NEJMoa2411668 https://www.nejm.org/doi/full/10.1056/NEJMoa2408954

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app